Erlotinib treatment results in patients with advanced non-small-cell lung cancer (NSCLC)—Influence of clinical predictors

• Authors: SALAJKA F.; PEŠEK M.; SKŘIČKOVÁ Jana; ZATLOUKAL P.; KOUBKOVÁ L.; GRYGÁRKOVÁ Y.; HRNČIARIK M.; HEJDUK Karel
• Year of publication: 2012
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine

Attached files

• Skrickovlung_cancer_004.pdf

• Description: The Czech Tarceva Register collects data concerning all NSCLC patients treated with erlotinib in the Czech Republic. Increasing number of classified patients makes possible to analyze factors influencing the treatment results.